NeuroFrontiers

Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial

Episode description: Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche, Basel, Switzerland, discusses the science behind PrevenTRON, a prev

Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection

Dr. Michael Irizarry, Senior Vice-President, Clinical Research, Eisai, Nutley, NJ, discusses the evidence supporting subcutaneous lecanemab for early Alzheimer disease, i

Next-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease

In this episode, Luka Kulic, MD, Vice President and Global Head of Early Clinical Development in Neuroscience and Rare Diseases at Roche, Basel, Switzerland, discusses th

Advancing MOGAD Care

Episode Description: What do the latest METEOROID trial results mean for neurologists treating myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)? Mi

Generalized Myasthenia Gravis: Inside the MINT Trial and CD19 B-Cell Therapy Advances

Richard J. Nowak, MD, MS, Associate Professor of Neurology, Yale School of Medicine, Yale University, New Haven, CT and global principal investigator of the Myasthenia Gr

Ocrevus Treatment in Pregnant and Lactating Women with Multiple Sclerosis

Riley Bove, MD, UCSF School of Medicine, San Francisco, CA details results from the MINORE and SOPRANINO studies examining Ocrevus treatment in pregnant and lactating wom

The Use of Intracranial Vessel Wall MRI for the Diagnosis of Vasculitis

Jae W. Song, MD, MS, Associate Professor of Radiology at the University of Pennsylvania, Philadelphia, PA, discusses the diagnostic value of intracranial vessel wall MRI

New Guidelines for the Assessment of Traumatic Brain Injury

Beth McQuiston, MD, RD, Medical Director, Abbott, Abbott Park, IL, and David Okonkwo, MD, PhD, Professor of Neurological Surgery, University of Pittsburgh, Pittsburg, PA,

The Impact of High Efficacy DMTs on Paramagnetic Rim Lesions

Jack Reeves, PhD, researcher at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, discusses results of a study which demonstrated

Proposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm

Preventable harm is a serious concern for patients with Parkinson disease who receive care in the hospital setting, even when admitted for reasons other than their diagno

Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome

Joseph Sullivan, MD, Professor, UCSF School of Medicine, San Francisco, CA, describes encouraging results from the SWALLOWTAIL and LONGWING studies of an investigational

Vagus Nerve Stimulation: Effects Beyond the Nervous System

Stavros Zanos, MD, PhD, Associate Professor, Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, uses neurostimulation as a means to study the

The Role of Advanced Genomic Testing in the Diagnosis and Treatment of Neurologic Conditions

Paul Kruszka, MD, Chief Medical Officer at GeneDx, discusses advanced genomic testing, emphasizing how these tests are used to guide diagnosis and treatment decisions ass

Physicians with Substance Use Disorder, Part II: Available Treatment and Recovery Options

Chris Bundy, MD, Executive Medical Director, Washington Physicians Health Program, provides an overview of treatment and recovery options available to physicians with sub

Physicians with Substance Use Disorder, Part I: Overview and A Personal Journey Through Recovery

Chris Bundy, MD, Executive Medical Director, Washington Physicians Health Program, provides an overview of physician substance use disorder, including prevalence, risk fa

Discussing Disparities in MS Care for Underrepresented Populations

In this episode, Trisham Gyang, MD, Clinical Assistant Professor of Neurology, The Ohio State University Wexner Medical Center, and Gopika Govindan Kutty, MD, Fellow, Dep